id	sid	eid	entity	type
ajlm-2522	1	1	emmanuel o. babafemi	PERSON
ajlm-2522	1	2	liverpool john moores university	ORG
ajlm-2522	1	3	liverpool	GPE
ajlm-2522	1	4	united kingdom benny	GPE
ajlm-2522	1	5	cherian department of microbiology	ORG
ajlm-2522	1	6	royal london hospital	ORG
ajlm-2522	1	7	london	GPE
ajlm-2522	1	8	united kingdom khalid	GPE
ajlm-2522	1	9	liverpool john moores university	ORG
ajlm-2522	1	10	liverpool	GPE
ajlm-2522	1	11	united kingdom	GPE
ajlm-2522	1	12	gilbert m. mogoko	PERSON
ajlm-2522	1	13	first	ORDINAL
ajlm-2522	1	14	dobson house	PERSON
ajlm-2522	1	15	bentalls	GPE
ajlm-2522	1	16	basildon	GPE
ajlm-2522	1	17	united kingdom	GPE
ajlm-2522	1	18	afe babalola university	ORG
ajlm-2522	1	19	ado ekiti	PERSON
ajlm-2522	1	20	nigeria	GPE
ajlm-2522	1	21	cherian bp	PERSON
ajlm-2522	1	22	rahman k	PERSON
ajlm-2522	1	23	mogoko gm	PERSON
ajlm-2522	1	24	abiola oo.	ORG
ajlm-2522	3	1	afr j	PERSON
ajlm-2522	4	1	2025;14(1	CARDINAL
ajlm-2522	5	1	1	CARDINAL
ajlm-2522	5	2	emmanuel o. babafemi	PERSON
ajlm-2522	5	3	benny p. cherian	PERSON
ajlm-2522	5	4	khalid rahman	PERSON
ajlm-2522	5	5	gilbert m. mogoko	PERSON
ajlm-2522	5	6	abiola	PERSON
ajlm-2522	5	7	05 june 2024	DATE
ajlm-2522	5	8	24 jan. 2025	DATE
ajlm-2522	5	9	16 apr	CARDINAL
ajlm-2522	6	1	2025	CARDINAL
ajlm-2522	6	2	2025	CARDINAL
ajlm-2522	11	1	3–7 days	DATE
ajlm-2522	14	1	rt-pcr)-based	ORG
ajlm-2522	15	1	01 january 1995	DATE
ajlm-2522	15	2	31 july 2023	DATE
ajlm-2522	19	1	twenty-seven	CARDINAL
ajlm-2522	19	2	99%	PERCENT
ajlm-2522	19	3	95%	PERCENT
ajlm-2522	19	4	99–100	CARDINAL
ajlm-2522	19	5	100%	PERCENT
ajlm-2522	19	6	95%	PERCENT
ajlm-2522	19	7	100–100	CARDINAL
ajlm-2522	19	8	350.67	CARDINAL
ajlm-2522	19	9	0.02	CARDINAL
ajlm-2522	19	10	0.01–0.03	CARDINAL
ajlm-2522	19	11	23 064.05	CARDINAL
ajlm-2522	19	12	95%	PERCENT
ajlm-2522	19	13	346.77	CARDINAL
ajlm-2522	19	14	0.99	CARDINAL
ajlm-2522	20	1	0.001	CARDINAL
ajlm-2522	25	1	approximately 156 million	CARDINAL
ajlm-2522	25	2	7.4 million	CARDINAL
ajlm-2522	25	3	annually	DATE
ajlm-2522	25	4	3.1%.3	CARDINAL
ajlm-2522	28	1	75% to 89%	PERCENT
ajlm-2522	28	2	between 2 days	DATE
ajlm-2522	28	3	7 days	DATE
ajlm-2522	33	1	guidelines13	ORG
ajlm-2522	33	2	1	CARDINAL
ajlm-2522	34	1	01 january 1995 to	DATE
ajlm-2522	34	2	31	CARDINAL
ajlm-2522	34	3	2023	CARDINAL
ajlm-2522	35	1	prospero	GPE
ajlm-2522	35	2	prospero crd42023435253	ORG
ajlm-2522	36	1	quadas-2)14	ORG
ajlm-2522	43	1	two	CARDINAL
ajlm-2522	43	2	2	CARDINAL
ajlm-2522	44	1	english	LANGUAGE
ajlm-2522	48	1	two	CARDINAL
ajlm-2522	49	1	three	CARDINAL
ajlm-2522	50	1	third	ORDINAL
ajlm-2522	52	1	1	CARDINAL
ajlm-2522	53	1	1	CARDINAL
ajlm-2522	53	2	2020	DATE
ajlm-2522	54	1	two	CARDINAL
ajlm-2522	54	2	microsoft	ORG
ajlm-2522	54	3	2016	DATE
ajlm-2522	54	4	1	CARDINAL
ajlm-2522	55	1	1	CARDINAL
ajlm-2522	56	1	four	CARDINAL
ajlm-2522	56	2	2).14	CARDINAL
ajlm-2522	56	3	3	CARDINAL
ajlm-2522	56	4	2	CARDINAL
ajlm-2522	58	1	95%	PERCENT
ajlm-2522	58	2	2	CARDINAL
ajlm-2522	59	1	dersimonian	NORP
ajlm-2522	62	1	1	CARDINAL
ajlm-2522	62	2	0.5	CARDINAL
ajlm-2522	62	3	1.4	CARDINAL
ajlm-2522	62	4	http://www.hrc.es/investigacion/metadisc_en.htm	DATE
ajlm-2522	62	5	5.4	CARDINAL
ajlm-2522	62	6	oxford	NORP
ajlm-2522	62	7	united kingdom).19,20,21	GPE
ajlm-2522	64	1	america	GPE
ajlm-2522	64	2	africa	LOC
ajlm-2522	64	3	asia-middle east	LOC
ajlm-2522	64	4	europe	LOC
ajlm-2522	65	1	1	CARDINAL
ajlm-2522	65	2	2	CARDINAL
ajlm-2522	65	3	1	CARDINAL
ajlm-2522	66	1	25	CARDINAL
ajlm-2522	66	2	50	CARDINAL
ajlm-2522	66	3	75	CARDINAL
ajlm-2522	66	4	90	CARDINAL
ajlm-2522	66	5	95%	PERCENT
ajlm-2522	67	1	2	CARDINAL
ajlm-2522	68	1	1022	CARDINAL
ajlm-2522	69	1	50	CARDINAL
ajlm-2522	70	1	an additional seven	CARDINAL
ajlm-2522	71	1	27	CARDINAL
ajlm-2522	71	2	22 742	QUANTITY
ajlm-2522	71	3	1	CARDINAL
ajlm-2522	72	1	22 742	CARDINAL
ajlm-2522	72	2	15	CARDINAL
ajlm-2522	73	1	1	CARDINAL
ajlm-2522	74	1	13	CARDINAL
ajlm-2522	74	2	america	GPE
ajlm-2522	74	3	5	CARDINAL
ajlm-2522	74	4	africa	LOC
ajlm-2522	74	5	5	CARDINAL
ajlm-2522	74	6	asia	LOC
ajlm-2522	74	7	middle east	LOC
ajlm-2522	74	8	4	CARDINAL
ajlm-2522	74	9	europe	LOC
ajlm-2522	75	1	1	CARDINAL
ajlm-2522	75	2	2	CARDINAL
ajlm-2522	77	1	27	CARDINAL
ajlm-2522	77	2	four	CARDINAL
ajlm-2522	77	3	2	CARDINAL
ajlm-2522	79	1	95%	PERCENT
ajlm-2522	79	2	99%	PERCENT
ajlm-2522	79	3	95%	PERCENT
ajlm-2522	79	4	99–100	CARDINAL
ajlm-2522	79	5	99%	PERCENT
ajlm-2522	79	6	95%	PERCENT
ajlm-2522	79	7	99–100	CARDINAL
ajlm-2522	80	1	0.99	CARDINAL
ajlm-2522	81	1	95%	PERCENT
ajlm-2522	81	2	46.19	CARDINAL
ajlm-2522	81	3	197.18	CARDINAL
ajlm-2522	81	4	159.14	CARDINAL
ajlm-2522	81	5	50.71	CARDINAL
ajlm-2522	81	6	68.07	CARDINAL
ajlm-2522	82	1	i2	ORG
ajlm-2522	82	2	between 43.7%	PERCENT
ajlm-2522	82	3	86.8%	PERCENT
ajlm-2522	83	1	2	CARDINAL
ajlm-2522	83	2	3	CARDINAL
ajlm-2522	83	3	4	CARDINAL
ajlm-2522	83	4	5	CARDINAL
ajlm-2522	83	5	6	CARDINAL
ajlm-2522	85	1	100%	PERCENT
ajlm-2522	85	2	100%	PERCENT
ajlm-2522	87	1	america	GPE
ajlm-2522	87	2	1	CARDINAL
ajlm-2522	87	3	13	CARDINAL
ajlm-2522	87	4	10 796	CARDINAL
ajlm-2522	87	5	99%	PERCENT
ajlm-2522	87	6	95%	PERCENT
ajlm-2522	87	7	98–100	CARDINAL
ajlm-2522	87	8	100%	PERCENT
ajlm-2522	87	9	95%	PERCENT
ajlm-2522	87	10	99–100	DATE
ajlm-2522	87	11	0.99	CARDINAL
ajlm-2522	88	1	america	GPE
ajlm-2522	88	2	95%	PERCENT
ajlm-2522	88	3	32.20	CARDINAL
ajlm-2522	88	4	82.52	CARDINAL
ajlm-2522	88	5	46.44	CARDINAL
ajlm-2522	88	6	37.20	CARDINAL
ajlm-2522	88	7	43.06	CARDINAL
ajlm-2522	89	1	i2	ORG
ajlm-2522	89	2	between 62.7%	PERCENT
ajlm-2522	89	3	85.50%	PERCENT
ajlm-2522	90	1	rt-pcr-based assay	ORG
ajlm-2522	90	2	america	GPE
ajlm-2522	90	3	1	CARDINAL
ajlm-2522	90	4	7	CARDINAL
ajlm-2522	91	1	africa	LOC
ajlm-2522	91	2	1	CARDINAL
ajlm-2522	91	3	5	CARDINAL
ajlm-2522	91	4	1178	CARDINAL
ajlm-2522	91	5	99%	PERCENT
ajlm-2522	91	6	95%	PERCENT
ajlm-2522	91	7	99–100	CARDINAL
ajlm-2522	91	8	99%	PERCENT
ajlm-2522	91	9	95%	PERCENT
ajlm-2522	91	10	0.99	CARDINAL
ajlm-2522	92	1	africa	LOC
ajlm-2522	92	2	95%	PERCENT
ajlm-2522	92	3	7.10	CARDINAL
ajlm-2522	92	4	34.88	CARDINAL
ajlm-2522	92	5	27.77	CARDINAL
ajlm-2522	92	6	6.09	CARDINAL
ajlm-2522	92	7	5.42	CARDINAL
ajlm-2522	93	1	i2	ORG
ajlm-2522	93	2	between 26.2%	PERCENT
ajlm-2522	93	3	88.50%	PERCENT
ajlm-2522	94	1	rt-pcr-based	ORG
ajlm-2522	94	2	africa	LOC
ajlm-2522	94	3	1	CARDINAL
ajlm-2522	94	4	8	CARDINAL
ajlm-2522	95	1	asia	LOC
ajlm-2522	95	2	middle east	LOC
ajlm-2522	95	3	1	CARDINAL
ajlm-2522	95	4	5	CARDINAL
ajlm-2522	95	5	3967	CARDINAL
ajlm-2522	95	6	100%	PERCENT
ajlm-2522	95	7	95%	PERCENT
ajlm-2522	95	8	98–100	CARDINAL
ajlm-2522	95	9	100%	PERCENT
ajlm-2522	95	10	95%	PERCENT
ajlm-2522	95	11	100–100	CARDINAL
ajlm-2522	95	12	0.99	CARDINAL
ajlm-2522	96	1	asia	LOC
ajlm-2522	96	2	middle east	LOC
ajlm-2522	96	3	95%	PERCENT
ajlm-2522	96	4	0.00	CARDINAL
ajlm-2522	96	5	0.00	CARDINAL
ajlm-2522	96	6	1.95	CARDINAL
ajlm-2522	96	7	4.58	CARDINAL
ajlm-2522	96	8	3.99	CARDINAL
ajlm-2522	96	9	1	CARDINAL
ajlm-2522	97	1	i2	ORG
ajlm-2522	97	2	between 0.00% and 12.70%	PERCENT
ajlm-2522	98	1	rt-pcr-based	ORG
ajlm-2522	98	2	asia	LOC
ajlm-2522	98	3	middle east	LOC
ajlm-2522	98	4	1	CARDINAL
ajlm-2522	98	5	9	CARDINAL
ajlm-2522	99	1	europe	LOC
ajlm-2522	99	2	1	CARDINAL
ajlm-2522	99	3	4	CARDINAL
ajlm-2522	99	4	6830	DATE
ajlm-2522	99	5	100 (	PERCENT
ajlm-2522	99	6	95%	PERCENT
ajlm-2522	99	7	97–100	CARDINAL
ajlm-2522	99	8	100 (	PERCENT
ajlm-2522	99	9	95%	PERCENT
ajlm-2522	99	10	99–100	DATE
ajlm-2522	99	11	0.99	CARDINAL
ajlm-2522	100	1	europe	LOC
ajlm-2522	100	2	95%	PERCENT
ajlm-2522	100	3	0.00	CARDINAL
ajlm-2522	100	4	0.00	CARDINAL
ajlm-2522	100	5	2.04	CARDINAL
ajlm-2522	100	6	2.91	CARDINAL
ajlm-2522	100	7	3.22	CARDINAL
ajlm-2522	100	8	1	CARDINAL
ajlm-2522	101	1	i2	ORG
ajlm-2522	101	2	between 0.00% and 6.8%	PERCENT
ajlm-2522	102	1	rt-pcr-based assay	ORG
ajlm-2522	102	2	europe	LOC
ajlm-2522	102	3	1	CARDINAL
ajlm-2522	102	4	10	CARDINAL
ajlm-2522	104	1	several days	DATE
ajlm-2522	108	1	34.9%	PERCENT
ajlm-2522	108	2	78%	PERCENT
ajlm-2522	108	3	100%’.52	CARDINAL
ajlm-2522	108	4	34.2%	PERCENT
ajlm-2522	108	5	58.5%	PERCENT
ajlm-2522	110	1	uk	GPE
ajlm-2522	111	1	414)55	CARDINAL
ajlm-2522	113	1	99%	PERCENT
ajlm-2522	113	2	95%	PERCENT
ajlm-2522	113	3	99–100	CARDINAL
ajlm-2522	113	4	350.67	CARDINAL
ajlm-2522	113	5	0.018	CARDINAL
ajlm-2522	114	1	350	CARDINAL
ajlm-2522	114	2	350-fold	CARDINAL
ajlm-2522	115	1	2	CARDINAL
ajlm-2522	124	1	99%	PERCENT
ajlm-2522	124	2	95%	PERCENT
ajlm-2522	124	3	99–100	CARDINAL
ajlm-2522	126	1	katherine stephan	PERSON
ajlm-2522	126	2	liverpool john moores university	ORG
ajlm-2522	132	1	k.r.	GPE
ajlm-2522	135	1	k.r.	GPE
ajlm-2522	147	1	2023	CARDINAL
ajlm-2522	147	2	april 18	DATE
ajlm-2522	148	1	geneva	PERSON
ajlm-2522	148	2	2021	CARDINAL
ajlm-2522	149	1	schwebke jr	PERSON
ajlm-2522	149	2	hobbs mm	PERSON
ajlm-2522	149	3	taylor sn	PERSON
ajlm-2522	150	1	u.s.	GPE
ajlm-2522	151	1	j clin microbiol	PERSON
ajlm-2522	153	1	sutton m	PERSON
ajlm-2522	153	2	sternberg m	PERSON
ajlm-2522	154	1	the united states	GPE
ajlm-2522	154	2	2001–2004	CARDINAL
ajlm-2522	155	1	clin infect dis	ORG
ajlm-2522	156	1	2007;45(10):1319–1326	CARDINAL
ajlm-2522	158	1	workowski ka	PERSON
ajlm-2522	158	2	berman sm	PERSON
ajlm-2522	159	1	mmwr recomm	PERSON
ajlm-2522	161	1	2006	DATE
ajlm-2522	162	1	2023	CARDINAL
ajlm-2522	163	1	hobbs mm	PERSON
ajlm-2522	163	2	sena ac	PERSON
ajlm-2522	163	3	swygard h	ORG
ajlm-2522	165	1	stamm	PERSON
ajlm-2522	165	2	piot p	PERSON
ajlm-2522	168	1	4	CARDINAL
ajlm-2522	168	2	new york	GPE
ajlm-2522	168	3	ny	GPE
ajlm-2522	168	4	mcgraw-hill medical	ORG
ajlm-2522	168	5	2008	DATE
ajlm-2522	169	1	771–793	CARDINAL
ajlm-2522	170	1	rj	ORG
ajlm-2522	170	2	kaldor jm	PERSON
ajlm-2522	173	1	2014;41(6):369–376	CARDINAL
ajlm-2522	174	1	schwebke jr	PERSON
ajlm-2522	176	1	2009;200(2):e1–188.e7	CARDINAL
ajlm-2522	177	1	krieger j n	PERSON
ajlm-2522	177	2	tam	PERSON
ajlm-2522	177	3	stevens ce	PERSON
ajlm-2522	179	1	jama	PERSON
ajlm-2522	180	1	1988;259(8):1223–1227	CARDINAL
ajlm-2522	181	1	mcgregor ja	PERSON
ajlm-2522	183	1	clin obstet gynecol	ORG
ajlm-2522	185	1	patil mj	PERSON
ajlm-2522	185	2	nagamoti jm	PERSON
ajlm-2522	185	3	metgud sc	ORG
ajlm-2522	189	1	2012;4(1):22–25	CARDINAL
ajlm-2522	190	1	bos pa	PERSON
ajlm-2522	190	2	möller lv	PERSON
ajlm-2522	191	1	trichomonas vaginalis	ORG
ajlm-2522	193	1	2007;68(2):243–247	CARDINAL
ajlm-2522	193	2	sobngwi-tambekou	PERSON
ajlm-2522	195	1	2009;85(2):116–120	CARDINAL
ajlm-2522	196	1	mckenzie je	PERSON
ajlm-2522	196	2	bossuyt	GPE
ajlm-2522	197	1	2020	DATE
ajlm-2522	198	1	syst	ORG
ajlm-2522	199	1	2021;10:89	CARDINAL
ajlm-2522	200	1	whiting pf	PERSON
ajlm-2522	200	2	westwood	PERSON
ajlm-2522	202	1	ann intern med	PERSON
ajlm-2522	203	1	2011;155(8):529–536	CARDINAL
ajlm-2522	203	2	dickersin k.	PERSON
ajlm-2522	204	1	rothstein hr	PERSON
ajlm-2522	204	2	sutton aj	PERSON
ajlm-2522	206	1	chichester	PERSON
ajlm-2522	206	2	wiley	PERSON
ajlm-2522	206	3	2005	DATE
ajlm-2522	206	4	11–33	CARDINAL
ajlm-2522	207	1	deville wl	PERSON
ajlm-2522	207	2	buntinx f	PERSON
ajlm-2522	208	1	bmc med res methodol	ORG
ajlm-2522	209	1	2002;2:9–12	CARDINAL
ajlm-2522	210	1	macaskill p	ORG
ajlm-2522	210	2	glasziou p	PERSON
ajlm-2522	210	3	fahey m. meta-analytic	PERSON
ajlm-2522	211	1	j clin epidemiol	PERSON
ajlm-2522	211	2	1995;48:119–130	CARDINAL
ajlm-2522	213	1	egger m	PERSON
ajlm-2522	213	2	altman	PERSON
ajlm-2522	215	1	323	CARDINAL
ajlm-2522	216	1	london	GPE
ajlm-2522	216	2	2001	DATE
ajlm-2522	216	3	248–282	CARDINAL
ajlm-2522	217	1	zamora j	ORG
ajlm-2522	217	2	abraira	PERSON
ajlm-2522	217	3	khan k	PERSON
ajlm-2522	217	4	a. meta	PERSON
ajlm-2522	218	1	bmc med res methodol	ORG
ajlm-2522	219	1	2006;6:31–42	CARDINAL
ajlm-2522	221	1	5.4	CARDINAL
ajlm-2522	222	1	may 2020	DATE
ajlm-2522	224	1	2023	CARDINAL
ajlm-2522	225	1	dersimonian	NORP
ajlm-2522	225	2	laird n. meta-analysis	PERSON
ajlm-2522	226	1	control clin trials	ORG
ajlm-2522	227	1	1986;7(3):177–188	CARDINAL
ajlm-2522	227	2	leeflang mm	PERSON
ajlm-2522	227	3	deeks jj	PERSON
ajlm-2522	227	4	takwoingi y	PERSON
ajlm-2522	227	5	macaskill p. cochrane	PERSON
ajlm-2522	228	1	syst	ORG
ajlm-2522	228	2	2013;2:82–87	ORG
ajlm-2522	229	1	jg	PERSON
ajlm-2522	229	2	bossuyt	PERSON
ajlm-2522	232	1	higgins jp	PERSON
ajlm-2522	232	2	green s. cochrane	PERSON
ajlm-2522	234	1	2023	CARDINAL
ajlm-2522	237	1	bmc med res methodol	ORG
ajlm-2522	238	1	2012;12:111	PERSON
ajlm-2522	239	1	https://doi.org/10.1186/1471-2288-12-111	GPE
ajlm-2522	239	2	alikhani m	PERSON
ajlm-2522	239	3	hosseini sa	PERSON
ajlm-2522	239	4	rezaei	ORG
ajlm-2522	239	5	mirzaei a.	PERSON
ajlm-2522	239	6	iran	GPE
ajlm-2522	241	1	2021;10(1):135–143	CARDINAL
ajlm-2522	242	1	bandea ci	PERSON
ajlm-2522	242	2	joseph k	PERSON
ajlm-2522	242	3	secor	GPE
ajlm-2522	244	1	j clin microbiol	PERSON
ajlm-2522	245	1	2013;51(4):1298–1300	CARDINAL
ajlm-2522	246	1	bui htv	PERSON
ajlm-2522	246	2	bui ht	PERSON
ajlm-2522	246	3	chu sv	PERSON
ajlm-2522	247	1	nine	CARDINAL
ajlm-2522	248	1	plos one	PERSON
ajlm-2522	249	1	2023;18(3):e0282439	CARDINAL
ajlm-2522	250	1	https://doi.org/10.1371/journal.pone.0282439 caliendo am	PERSON
ajlm-2522	250	2	jordan ja	PERSON
ajlm-2522	250	3	ingersoll j	PERSON
ajlm-2522	250	4	gm	ORG
ajlm-2522	253	1	2005;13(3):145–150	CARDINAL
ajlm-2522	253	2	abbai n. genotypic	PERSON
ajlm-2522	253	3	south african	NORP
ajlm-2522	256	1	https://doi.org/10.1155/2020/1687427	CARDINAL
ajlm-2522	256	2	clifton s	PERSON
ajlm-2522	256	3	alexander s	PERSON
ajlm-2522	257	1	british	NORP
ajlm-2522	259	1	2018;94(4):226–229	CARDINAL
ajlm-2522	259	2	hobbs m	PERSON
ajlm-2522	259	3	marrazzo j	PERSON
ajlm-2522	262	1	2016;43(6):369–373	CARDINAL
ajlm-2522	263	1	hardick j	PERSON
ajlm-2522	263	2	roche	ORG
ajlm-2522	264	1	j clin microbiol	PERSON
ajlm-2522	266	1	shin w	PERSON
ajlm-2522	266	2	yang h	PERSON
ajlm-2522	267	1	2	CARDINAL
ajlm-2522	267	2	south korea	GPE
ajlm-2522	268	1	korean	NORP
ajlm-2522	269	1	2016;54(1):75–80	CARDINAL
ajlm-2522	270	1	hodson j	PERSON
ajlm-2522	270	2	ross jdc	PERSON
ajlm-2522	274	1	seok c	PERSON
ajlm-2522	274	2	yun sa	PERSON
ajlm-2522	275	1	sti6	PERSON
ajlm-2522	275	2	six	CARDINAL
ajlm-2522	276	1	j clin	PERSON
ajlm-2522	277	1	2019;33:6	CARDINAL
ajlm-2522	278	1	sri lanka	GPE
ajlm-2522	279	1	plos one	PERSON
ajlm-2522	280	1	2021;16(10):e0258556	CARDINAL
ajlm-2522	281	1	jordan ja	PERSON
ajlm-2522	281	2	lowery d	GPE
ajlm-2522	281	3	trucco m. taqman	PERSON
ajlm-2522	282	1	j clin microbiol	PERSON
ajlm-2522	284	1	lawing lf	PERSON
ajlm-2522	284	2	hedges sr	PERSON
ajlm-2522	284	3	schwebke jr.	PERSON
ajlm-2522	285	1	j clin microbiol	PERSON
ajlm-2522	287	1	morris sr	PERSON
ajlm-2522	287	2	bristow cc	PERSON
ajlm-2522	287	3	wierzbicki	PERSON
ajlm-2522	287	4	et al	PERSON
ajlm-2522	289	1	lancet	ORG
ajlm-2522	290	1	2021;21(5):668–676	CARDINAL
ajlm-2522	291	1	o	DATE
ajlm-2522	291	2	sowinski s	PERSON
ajlm-2522	292	1	uganda	GPE
ajlm-2522	293	1	bmc res	ORG
ajlm-2522	294	1	2017;10:259	CARDINAL
ajlm-2522	294	2	https://doi.org/10.1186/s13104-017-2581-1 mitchev n	PERSON
ajlm-2522	294	3	singh	GPE
ajlm-2522	294	4	garrett n	PERSON
ajlm-2522	294	5	niehaus aj	PERSON
ajlm-2522	295	1	mlisana kp	PERSON
ajlm-2522	295	2	south african	NORP
ajlm-2522	296	1	afr j	PERSON
ajlm-2522	297	1	2021;10(1):4	CARDINAL
ajlm-2522	299	1	argentina	GPE
ajlm-2522	300	1	korean	NORP
ajlm-2522	301	1	2016;54(2):191–195	CARDINAL
ajlm-2522	301	2	https://doi.org/10.3347/kjp.2016.54.2.191 pillay	PERSON
ajlm-2522	301	3	fehler g	PERSON
ajlm-2522	301	4	ballard rc	ORG
ajlm-2522	303	1	2007;83:126–129	DATE
ajlm-2522	306	1	2018;45(5):332–336	CARDINAL
ajlm-2522	307	1	saha	PERSON
ajlm-2522	307	2	das s.	PERSON
ajlm-2522	309	1	2020;10(2):124–129	CARDINAL
ajlm-2522	311	1	allplex sti	PERSON
ajlm-2522	312	1	plos one	PERSON
ajlm-2522	313	1	2019;14(9):9	CARDINAL
ajlm-2522	314	1	https://doi.org/10.1371/journal.pone.0222439 saleh am	PERSON
ajlm-2522	314	2	abdalla hs	PERSON
ajlm-2522	314	3	satti ab	PERSON
ajlm-2522	314	4	adam i. diagnosis	PERSON
ajlm-2522	314	5	khartoum	GPE
ajlm-2522	314	6	sudan.	GPE
ajlm-2522	316	1	2014;9(49):5	CARDINAL
ajlm-2522	316	2	souza rp	PERSON
ajlm-2522	316	3	de abreu lpa	PERSON
ajlm-2522	316	4	ferreira ec	PERSON
ajlm-2522	316	5	seven	CARDINAL
ajlm-2522	316	6	brazilian	NORP
ajlm-2522	316	7	multiplex	NORP
ajlm-2522	317	1	j trop med	PERSON
ajlm-2522	318	1	2013;89(6):1199–1202	CARDINAL
ajlm-2522	319	1	https://doi.org/10.4269/ajtmh.13-0315 sutcliffe s	PERSON
ajlm-2522	319	2	newman sb	PERSON
ajlm-2522	319	3	hardick	PERSON
ajlm-2522	322	1	2010;37(9):585–590	CARDINAL
ajlm-2522	322	2	https://doi.org/10.1097/olq.0b013e3181de4113 bruni l	ORG
ajlm-2522	322	3	diaz m	PERSON
ajlm-2522	322	4	castellsagué m	ORG
ajlm-2522	322	5	ferrer e	GPE
ajlm-2522	322	6	de sanjosé s.	ORG
ajlm-2522	322	7	5	CARDINAL
ajlm-2522	322	8	1 million	CARDINAL
ajlm-2522	324	1	2010;202(12):1789–1799	CARDINAL
ajlm-2522	328	1	2003;79(5):393–398	CARDINAL
ajlm-2522	329	1	smith ks	GPE
ajlm-2522	329	2	tabrizi sn	PERSON
ajlm-2522	331	1	2005;16:811–821	CARDINAL
ajlm-2522	332	1	cherian bp	PERSON
ajlm-2522	332	2	banting l	PERSON
ajlm-2522	332	3	ga	ORG
ajlm-2522	332	4	ngianga k.	PERSON
ajlm-2522	334	1	2017;6(1):215	CARDINAL
ajlm-2522	334	2	edwards t	PERSON
ajlm-2522	334	3	burke p	ORG
ajlm-2522	334	4	smalley h	ORG
ajlm-2522	334	5	hobbs g. trichomonas	PERSON
ajlm-2522	337	1	chopra kk	PERSON
ajlm-2522	338	1	singh s. newer diagnostic	ORG
ajlm-2522	339	1	curr med res pract	ORG
ajlm-2522	340	1	2020;10(1):8–11	CARDINAL
ajlm-2522	341	1	christopher dj	PERSON
ajlm-2522	341	2	schumacher sg	PERSON
ajlm-2522	341	3	michael js	PERSON
ajlm-2522	341	4	xpert mtb	PERSON
ajlm-2522	342	1	eur respir j. 2013;42(5):1427–1429	PERSON
ajlm-2522	343	1	martindale	PRODUCT
ajlm-2522	343	2	collins	PERSON
ajlm-2522	344	1	acad emerg med	ORG
ajlm-2522	345	1	2016;23(3):223–242	CARDINAL
ajlm-2522	345	2	williams	PERSON
ajlm-2522	345	3	mannion	PERSON
ajlm-2522	346	1	bmc med res methodol	ORG
ajlm-2522	347	1	2020;20:137	DATE
ajlm-2522	347	2	https://doi.org/10.1186/s12874-020-01010-1 bossuyt	PERSON
ajlm-2522	347	3	reitsma jb	PERSON
ajlm-2522	347	4	bruns de	ORG
ajlm-2522	347	5	2015	CARDINAL
ajlm-2522	349	1	2015:351	CARDINAL